Endocannabinoidome

Erscheinungsjahr 2014
ISBN: 978-0-12-420126-2
Verlag: ACADEMIC PRESS

Buch, Englisch, 208 Seiten, Format (B × H): 151 mm x 228 mm, Gewicht: 306 g

The Endocannabinoidome: The World of Endocannabinoids and Related Mediators is dedicated to the latest research and studies on endocannabinoids and cannabinoid receptors to illustrate their important role in the discovery of new, endocannabinoid-related, lipid mediators. Written by leading experts across different disciplines, this book focuses on the biochemical and anlayticial aspects of novel lipid signals, their pharmacological activities and their potential utilization for the development of new and effective therapeutic strategies. The first book of its kind, The Endocannabinoidome is a meaningful reference for all those involved in experimental efforts to further the development of this field.

Zielgruppe

Pharmacologists and pharmaceutical scientists conducting research in the area of endocannabinoids; biochemists, toxicologists, neuroscientists, clinical researchers and physicians

Autoren/Hrsg.

Di Marzo, Vincenzo

Wang, Jenny

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

Introduction
- Non-endocannabinoid N-acylethanolamines and Monoacylglycerols: Old Molecules, New Targets
- Omega-3 Polyunsaturated N-acylethanolamines: A Link Between Diet and Cellular Biology
- Lipoaminoacids: A Combinatoral World of New Lipid Signals
- Oxidative Metabolites of Endocannabinoids Formed by Cycloocygenase-2
- N-acyldopamines and N-acylserotonins: From Synthetic Pharmacological Tools to Endogenous Multi-Target Mediators
- The Pharmacology of Prostaglandin F2a Ethanolamide and Bimatoprost Reveals a Unique Feed-Back Mechanism on Endocannabinoid Actions
- Prostamide F2a Biosynthesizing Enzymes
- Metabolic Enzymes for Endocannabinoids and Endocannabinoid-like Mediators
- Endocannabinoidomics: "Omics" Approaches Applied to Endocannabinoids and Endocannabinoid-like Mediators
- Common Receptors for Endocannabinoid-like Mediators and Plant Cannabinoids

Über Autor(innen)

Wang, Jenny
Jenny W. Wang obtained a BS from Peking University in China, a MS from the University of California at Los Angeles (UCLA) in the USA, and a Ph.D. from the University of Aberdeen in the UK. Dr. Wang’s professional discipline includes biochemistry, molecular/cellular biology, and pharmacology with experience in anti-cancer, potassium channel, retinoid, and eicosanoid research. She gained extensive knowledge on RNA, DNA, protein, lipid, and assay development while working at City of Hope, California Institute of Technology, Beckman Instruments and Allergan Inc. Dr. Wang is a researcher with a passion in drug discovery. She is currently a Research Investigator on the fatty acid amides program and the team leader on prostamides for hair growth at Allergan, California, USA, where she particularly focuses on eicosanoid research. Her major current therapeutic interests are inflammation and hair growth. In addition to her own research, Dr. Wang enjoys the interaction with academic collaborators and contract research organizations. Dr. Wang is an author of 30 peer-reviewed publications, an inventor on 34 patents (3 granted, 18 published, 13 pending), and has been invited speaker/session chairman at various scientific meetings.